Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) Invested Capital (2020 - 2025)

Rapid Micro Biosystems' Invested Capital history spans 6 years, with the latest figure at $53.2 million for Q4 2025.

  • On a quarterly basis, Invested Capital fell 29.39% to $53.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $53.2 million, a 29.39% decrease, with the full-year FY2025 number at $53.2 million, down 29.39% from a year prior.
  • Invested Capital hit $53.2 million in Q4 2025 for Rapid Micro Biosystems, down from $64.3 million in the prior quarter.
  • Over the last five years, Invested Capital for RPID hit a ceiling of $234.7 million in Q3 2021 and a floor of -$164.5 million in Q2 2021.
  • Historically, Invested Capital has averaged $101.1 million across 5 years, with a median of $112.0 million in 2023.
  • The widest YoY moves for Invested Capital: up 306.25% in 2021, down 59.38% in 2021.
  • Tracing RPID's Invested Capital over 5 years: stood at $221.0 million in 2021, then dropped by 25.71% to $164.2 million in 2022, then decreased by 28.13% to $118.0 million in 2023, then plummeted by 36.14% to $75.4 million in 2024, then decreased by 29.39% to $53.2 million in 2025.
  • Business Quant data shows Invested Capital for RPID at $53.2 million in Q4 2025, $64.3 million in Q3 2025, and $54.5 million in Q2 2025.